Ampersand-backed Nexelis acquires AIT Bioscience
Nexelis, a portfolio company of Ampersand Capital Partners, has acquired AIT Bioscience, an Indianapolis-based bioanalytical contract research organization.
22 July 2020•3 mins read
Nexelis, a portfolio company of Ampersand Capital Partners, has acquired AIT Bioscience, an Indianapolis-based bioanalytical contract research organization.
GrowthCurve Capital takes majority stake in medication access platform TailorMed
10 hours ago · 1 min read
OpenGate Capital completes carve-out of Maersk Training from Maersk
12 hours ago · 1 min read
Stonepeak completes acquisition of 65% Castrol stake from BP
13 hours ago · 1 min read
Livingbridge backs launch of accounting group Apteus after seven acquisitions
15 hours ago · 2 mins read
DPE-backed CirQono acquires Saxony demolition firm ORA in add-on deal
18 hours ago · 2 mins read
Charterhouse agrees to sell Vermeg stake to Advent, with ADIA co-investing
19 hours ago · 2 mins read
Apollo funds complete minority investment in Alpine-backed Apex Service Partners
30 October 2026 · 2 mins read
